Quest Diagnostics DGX
NYSE DGX
$244.63 -0.37 (-0.15%)
As of: Aug 27, 2026 · 3:59 PM EDT

Quest Diagnostics (DGX) Liabilities from Discontinued Operations (2012 - 2013)

Quest Diagnostics (DGX) posted Liabilities from Discontinued Operations of 60363000.0 for Q1 2013, up 0.6% sequentially from 60000000.0 in Q4 2012.

Quest Diagnostics (DGX) Liabilities from Discontinued Operations (2012 - 2013) Analysis & Trends

Quest Diagnostics has reported Liabilities from Discontinued Operations for 2 years, with the latest figure at 60363000.0 in Q1 2013.

  • Quarterly Liabilities from Discontinued Operations changed N/A year-over-year to 60363000.0 in Q1 2013, while the trailing twelve-month figure through Mar 2013 was 60363000.0 (changed N/A YoY) and the FY2012 annual result came in at 60000000.0, changed N/A from the prior year.
  • Liabilities from Discontinued Operations rose to 60363000.0 in Q1 2013 per DGX's latest filing, from 60000000.0 in the prior quarter.
  • Over five years, Liabilities from Discontinued Operations peaked at 60363000.0 in Q1 2013 and troughed at 60000000.0 in Q4 2012.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 234.15 Bn 230.09 Bn 8.34 Bn
2 Danaher 152.10 Bn 147.75 Bn 3.61 Bn
3 Natera 48.48 Bn 47.38 Bn 486.15 Mn
4 Agilent Technologies 44.35 Bn 42.55 Bn 990.00 Mn
5 Iqvia Holdings 43.68 Bn 41.60 Bn 1.44 Bn
6 Idexx Laboratories 43.02 Bn 42.83 Bn 779.09 Mn
7 Illumina 34.39 Bn 33.22 Bn 770.00 Mn
8 Mettler Toledo International 28.29 Bn 28.24 Bn 650.22 Mn
9 Labcorp Holdings 27.51 Bn 27.37 Bn 1.11 Bn
10 Quest Diagnostics 27.10 Bn 26.47 Bn 1.03 Bn

Historic Data

Download Data
DateValue
Mar 31, 2013 60.36 Mn
Mar 31, 2013 60.36 Mn
Dec 31, 2012 60.00 Mn
Dec 31, 2012 60.00 Mn